168 related articles for article (PubMed ID: 27556459)
1. Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma.
Cheng S; Jiang X; Ding C; Du C; Owusu-Ansah KG; Weng X; Hu W; Peng C; Lv Z; Tong R; Xiao H; Xie H; Zhou L; Wu J; Zheng S
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556459
[TBL] [Abstract][Full Text] [Related]
2. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
[TBL] [Abstract][Full Text] [Related]
3. Nicotine-Induced ILF2 Facilitates Nuclear mRNA Export of Pluripotency Factors to Promote Stemness and Chemoresistance in Human Esophageal Cancer.
Li Y; Wang M; Yang M; Xiao Y; Jian Y; Shi D; Chen X; Ouyang Y; Kong L; Huang X; Bai J; Hu Y; Lin C; Song L
Cancer Res; 2021 Jul; 81(13):3525-3538. PubMed ID: 33975879
[TBL] [Abstract][Full Text] [Related]
4. ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells.
Du H; Le Y; Sun F; Li K; Xu Y
Anal Cell Pathol (Amst); 2019; 2019():1575031. PubMed ID: 30881868
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma.
Dong L; Xie L; Li M; Dai H; Wang X; Wang P; Zhang Q; Liu W; Hu X; Zhao M
Sci Rep; 2019 Oct; 9(1):14854. PubMed ID: 31619714
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
7. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
9. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
10. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
[TBL] [Abstract][Full Text] [Related]
11. SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway.
Ding J; Qin D; Zhang Y; Li Q; Li Y; Li J
Mol Med Rep; 2020 Mar; 21(3):1251-1257. PubMed ID: 31922244
[TBL] [Abstract][Full Text] [Related]
12. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis.
Xi Z; Huang H; Hu J; Yu Y; Ma X; Xu M; Ming J; Li L; Zhang H; Chen H; Huang T
J Exp Clin Cancer Res; 2024 Jan; 43(1):22. PubMed ID: 38238853
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
14. Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma.
Zhang X; Bustos MA; Gross R; Ramos RI; Takeshima TL; Mills GB; Yu Q; Hoon DSB
Clin Transl Med; 2021 Oct; 11(10):e608. PubMed ID: 34709752
[TBL] [Abstract][Full Text] [Related]
15. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo.
Wei W; Li L; Wang X; Yan L; Cao W; Zhan Z; Zhang X; Yu H; Xie Y; Xiao Q
Mol Med Rep; 2015 Jul; 12(1):905-12. PubMed ID: 25738600
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
[TBL] [Abstract][Full Text] [Related]
19. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
[TBL] [Abstract][Full Text] [Related]
20. Interleukin Enhancer Binding Factor 2 Regulates Cell Viability and Apoptosis of Human Brain Vascular Smooth Muscle Cells.
Wei L; Yang C; Wang G; Li K; Zhang Y; Guan H; Sun Z; Zhong C
J Mol Neurosci; 2021 Feb; 71(2):225-233. PubMed ID: 32748330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]